NIPRO JMI Pharma held a scientific seminar on “DPP-4 inhibitors & COVID-19 related outcomes among patients with type 2 diabetes”

NIPRO JMI Pharma Ltd. recently arranged a befitting scientific seminar on “DPP-4 inhibitors & COVID-19 related outcomes among patients with type 2 Diabetes” at hotel InterContinental, Dhaka. Distinguished Professor AK Azad Khan, President of Bangladesh Diabetic Association, adorned the session with his presence as a chief guest. Eminent endocrinologists Professor Md. Faruque Pathan & Professor. Dr. SM Ashrafuzzaman was present in the seminar as chairperson & co-chairperson, respectively.

The session speaker, a renowned endocrinologist Dr. Md. Feroz Amin presented that the use of DPP-4 inhibitors in COVID-19 patients with diabetes might significantly lower the probability of all-cause mortality and severe manifestations of COVID-19. Chief Guest, Professor AK Azad Khan, thanked NIPRO JMI Pharma for arranging such a scientific seminar in this current situation and praised for working with the Diabetic Association of Bangladesh as its scientific partner for a long time in diabetes prevention and treatment. Chairpersons & co-chairperson also admired NIPRO JMI Pharma for producing several groundbreaking medicines in Bangladesh within a short span of time, which has enriched the Diabetes management of Bangladesh.

  Learn about the COVID-19 pandemic from News Hour  

Mr. Md. Mizanur Rahman, the CEO of NIPRO JMI Pharma Ltd., placed his gratification to the clinicians for their amazing support in serving the ailing humanity with its world class products. He has also articulated that a good number of latest molecules will be launched soon in the continuation of its regular endeavors.

Follow News Hour
News Hour Correspondent

This article has been posted by a News Hour Correspondent. For queries, please contact through [email protected]
No Comments
Scroll Up
%d bloggers like this: